Molina, D., Pérez Beteta, J., Martínez González, A., Sepúlveda Sánchez, J. M., Peralta, S., Gil Gil, M., . . . Pérez García, V. M. (2016). Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
Citación estilo ChicagoMolina, David, et al. Geometrical Measures Obtained From Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits From Bevacizumab in Glioblastoma Patients. 2016.
Cita MLAMolina, David, et al. Geometrical Measures Obtained From Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits From Bevacizumab in Glioblastoma Patients. 2016.
Precaución: Estas citas no son 100% exactas.